Gee‐Chen Chang

9.1k citations

55 papers · 3.3k indexed · 1 hit paper · h-index 31

Molecular Biology top 5%
Pulmonary and Respiratory Medicine top 1%
Oncology top 2%
Cancer Research top 2%
Radiology, Nuclear Medicine and Imaging top 10%

Co-authors: Pan‐Chyr Yang Chih‐Yi Chen Sung‐Liang Yu Jeremy J.W. Chen Hsuan‐Yu Chen James Chih‐Hsin Yang Chiou-Ling Cheng Wing‐Kai Chan
Topics: Lung Cancer Treatments and Mutations (30 papers)Lung Cancer Diagnosis and Treatment (13 papers)Lung Cancer Research Studies (10 papers)
Cited by: Cancer Research Oncology Pulmonary and Respiratory Medicine
Journals: New England Journal of Medicine Journal of Clinical Oncology PLoS ONE
Partner nations: Taiwan United States China

In The Last Decade

Gee‐Chen Chang

54 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer

2007 693 citations Hsuan‐Yu Chen, Sung‐Liang Yu et al. profile →

Peers

Countries citing papers authored by Gee‐Chen Chang

Since Specialization

Citations

This map shows the geographic impact of Gee‐Chen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gee‐Chen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gee‐Chen Chang more than expected).

Fields of papers citing papers by Gee‐Chen Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gee‐Chen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gee‐Chen Chang. The network helps show where Gee‐Chen Chang may publish in the future.

Co-authorship network of co-authors of Gee‐Chen Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Gee‐Chen Chang. A scholar is included among the top collaborators of Gee‐Chen Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gee‐Chen Chang. Gee‐Chen Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects 2025 ·Cell Death and Disease ·Yi‐Jing Hsiao,Min-Shu Hsieh,Gee‐Chen Chang,(unknown),(unknown),Yan-Ming Chen,(unknown),Pan‐Chyr Yang,Sung‐Liang Yu	4
2	Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation 2024 ·Cancers ·(unknown),(unknown),Kuo-Hsuan Hsu,Jeng‐Sen Tseng,(unknown),Kun‐Chieh Chen,Gee‐Chen Chang,(unknown)	1
3	Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients 2021 ·OncoTargets and Therapy ·Kuo-Hsuan Hsu,Jing-Wen Huang,Jeng‐Sen Tseng,Kuan‐Wen Chen,(unknown),Sung‐Liang Yu,Tsung‐Ying Yang,(unknown),Jeremy J.W. Chen,Kun‐Chieh Chen,Gee‐Chen Chang	11
4	Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women 2020 ·Scientific Reports ·Tzu‐Yu Chen,(unknown),Huiling Chen,Chin‐Hao Chang,(unknown),Yi-Song Chen,(unknown),(unknown),Gee‐Chen Chang,Ying-Huang Tsai,Chih-Liang Wang,Yuh-Min Chen,Ming-Shyan Huang,Wu‐Chou Su,Pan‐Chyr Yang,Chien‐Jen Chen,Chin‐Fu Hsiao,Chao A. Hsiung	58
5	A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation–Positive NSCLC Patients 2019 ·Journal of Thoracic Oncology ·Giorgio V. Scagliotti,Denis Moro‐Sibilot,Jens Kollmeier,Adolfo Favaretto,Eun Kyung Cho,(unknown),Martin Kimmich,Nicolas Girard,Chun-Ming Tsai,Te‐Chun Hsia,Matteo Brighenti,Christian Schumann,Xuejing Aimee Wang,Sameera R. Wijayawardana,Aaron M. Gruver,Johan Wallin,(unknown),Volker Wacheck,Gee‐Chen Chang	60
6	Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report 2019 ·Journal of Thoracic Oncology ·James Chih‐Hsin Yang,Frances A. Shepherd,Dong‐Wan Kim,Gyeong‐Won Lee,Jong Seok Lee,Gee‐Chen Chang,Sung Sook Lee,Yu‐Feng Wei,(unknown),Gianluca Laus,Barbara Collins,(unknown),Leora Horn	164
7	EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer 2018 ·Lung Cancer ·Thomas John,Hiroaki Akamatsu,Angelo Delmonte,Wu‐Chou Su,Jong Seok Lee,Gee‐Chen Chang,Xiangning Huang,Suzanne Jenkins,Yi‐Long Wu	35
8	FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression 2017 ·Clinical Cancer Research ·(unknown),Gee‐Chen Chang,Yi‐Ju Chen,Yi‐Chiung Hsu,Yi‐Jing Hsiao,Kang‐Yi Su,Hsuan‐Yu Chen,Chien‐Yu Lin,Jin‐Shing Chen,Yu‐Ju Chen,Qi-Sheng Hong,(unknown),Chih‐Ying Wu,Bing‐Ching Ho,(unknown),Pan‐Chyr Yang,Sung‐Liang Yu	26
9	A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma 2016 ·Journal of Thoracic Oncology ·Tony Mok,Sarayut Lucien Geater,Wu‐Chou Su,Eng-Huat Tan,James Chih‐Hsin Yang,Gee‐Chen Chang,May Han,Philip Komarnitsky,Francis Payumo,Jennifer Garrus,Sandra Close,Keunchil Park	41
10	HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma 2015 ·PLoS ONE ·Chi-Chung Wang,Kang‐Yi Su,Hsuan‐Yu Chen,(unknown),(unknown),(unknown),(unknown),(unknown),Gee‐Chen Chang,Sung‐Liang Yu,Jeremy J.W. Chen	40
11	Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma 2015 ·Lung Cancer ·Jeng‐Sen Tseng,Chih-Liang Wang,Tsung‐Ying Yang,Chih‐Yi Chen,Cheng‐Ta Yang,Kun‐Chieh Chen,Kuo-Hsuan Hsu,C. J. Tsai,Gee‐Chen Chang	13
12	Shisa3 is Associated with Prolonged Survival Through Promoting β-Catenin Degradation in Lung Cancer 2014 ·American Journal of Respiratory and Critical Care Medicine ·Chun-Chieh Chen,Hsuan‐Yu Chen,Kang‐Yi Su,Qi-Sheng Hong,Bo‐Shiun Yan,Ching‐Hsien Chen,Szu‐Hua Pan,Yih‐Leong Chang,(unknown),Pei-Fang Hung,Shinsheng Yuan,Gee‐Chen Chang,Jeremy J.W. Chen,Pan‐Chyr Yang,Ya‐Chien Yang,Sung‐Liang Yu	33
13	The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma 2013 ·PLoS ONE ·Pei-Fang Hung,Tse‐Ming Hong,Yi‐Chiung Hsu,Hsuan‐Yu Chen,Yih‐Leong Chang,Chen‐Tu Wu,Gee‐Chen Chang,Yuh‐Shan Jou,Szu‐Hua Pan,Pan‐Chyr Yang	38
14	EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients 2011 ·Clinical Cancer Research ·Shi‐Yi Yang,Tsung‐Ying Yang,Kun‐Chieh Chen,Yao-Jen Li,Kuo-Hsuan Hsu,(unknown),Chih‐Yi Chen,Chung-Ping Hsu,Jiun‐Yi Hsia,Cheng-Yen Chuang,Ying-Huang Tsai,Kuan‐Yu Chen,Ming-Shyan Huang,Wu‐Chou Su,Yuh-Min Chen,Chao A. Hsiung,Chen‐Yang Shen,Gee‐Chen Chang,Pan‐Chyr Yang,Chien‐Jen Chen	26
15	A Four-Gene Signature from NCI-60 Cell Line for Survival Prediction in Non–Small Cell Lung Cancer 2009 ·Clinical Cancer Research ·Yi‐Chiung Hsu,Shinsheng Yuan,Hsuan‐Yu Chen,Sung‐Liang Yu,Chia-Hsin Liu,(unknown),(unknown),Chia‐Hung Lin,Gee‐Chen Chang,Ker-Chau Li,Pan‐Chyr Yang	42
16	Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma 2008 ·American Journal of Respiratory and Critical Care Medicine ·(unknown),Szu‐Hua Pan,Shuenn-Chen Yang,Sung‐Liang Yu,Ting-Fang Che,Chung‐Wu Lin,(unknown),Gee‐Chen Chang,(unknown),Yi-Ying Wu,Yung‐Chie Lee,Tse‐Ming Hong,Pan‐Chyr Yang	146
17	Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes 2006 ·Clinical Cancer Research ·Gee‐Chen Chang,Ko‐Jiunn Liu,Chia‐Ling Hsieh,(unknown),(unknown),(unknown),Kwen‐Tay Luh,Li‐Han Hsu,(unknown),Chou‐Chik Ting,Chih‐Yi Chen,Kun‐Chieh Chen,Tsung‐Ying Yang,Teh‐Ying Chou,(unknown),Jacqueline Whang‐Peng,Neng-Yao Shih	128
18	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer 2006 ·Cancer ·James Chih‐Hsin Yang,Jin‐Yuan Shih,Kun‐Chieh Chen,Chong‐Jen Yu,Tsung‐Ying Yang,(unknown),Wen‐Pin Su,Chien‐Hung Gow,Chiun Hsu,Gee‐Chen Chang,Pan‐Chyr Yang	51
19	Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway 2004 ·European Journal of Pharmacology ·Gee‐Chen Chang,Shih-Lan Hsu,(unknown),Wenjun Wu,Chih‐Yi Chen,Gwo‐Tarng Sheu	55
20	Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients 2004 ·Toxicology Letters ·Ming‐Fang Wu,Wenjun Wu,Gee‐Chen Chang,Chin‐Yi Chen,(unknown),(unknown),Huei Lee,Pinpin Lin	24

About Gee‐Chen Chang

Gee‐Chen Chang is a scholar working on Microbiology, Oncology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Diagnosis and Treatment (13 papers) and Lung Cancer Research Studies (10 papers). The work is most often cited by research in Cancer Research (784 citations), Oncology (1.4k citations) and Pulmonary and Respiratory Medicine (1.6k citations). Gee‐Chen Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Pan‐Chyr Yang, Chih‐Yi Chen, Sung‐Liang Yu, Jeremy J.W. Chen, Hsuan‐Yu Chen, James Chih‐Hsin Yang, Chiou-Ling Cheng, Wing‐Kai Chan, Wei J. Chen and Chun‐Houh Chen. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact